Perioperative risk of bleeding with antithrombotic agents in macular surgery: a national, prospective, multicentre study

Author:

Louison Solenne1,Gabrielle Pierre‐Henry12ORCID,Soudry Agnès3,Meillon Cyril1,Blanc Julie1,Béal Guillaume4,Arsène Sophie5,Le Mer Yannick6,Berrod Jean‐Paul7,Kodjikian Laurent8,Creuzot‐Garcher Catherine12ORCID,

Affiliation:

1. Department of Ophthalmology University Hospital Dijon France

2. Eye and Nutrition Research Group National Scientific Research Council (CNRS) National Institute of Agronomic Research (INRA) University of Burgundy Dijon France

3. Department of Clinical Research and Investigation University Hospital Dijon France

4. Department of Anaesthesiology University Hospital Dijon France

5. Department of Ophthalmology University Hospital Tours France

6. Department of Ophthalmology Rothschild Ophthalmologic Foundation Paris France

7. Department of Ophthalmology University Hospital Nancy France

8. Department of Ophthalmology Croix‐Rousse University Hospital Lyon France

Funder

CFSR Recherche

Publisher

Wiley

Subject

Ophthalmology,General Medicine

Reference30 articles.

1. Management of direct oral anticoagulants in patients undergoing elective surgeries and invasive procedures: Updated guidelines from the French Working Group on Perioperative Hemostasis (GIHP) – September 2015

2. ANSM (National Agency for Medicines and Health Products Safety)(2014):[Anticoagulant in France in 2014: review of state and monitoring].https://ansm.sante.fr/S‐informer/Points‐d‐information‐Points‐d‐information/Actualisation‐du‐rapport‐sur‐les‐anticoagulants‐en‐France‐Etat‐des‐lieux‐en‐2014‐et‐recommandations‐de‐surveillance‐Point‐d‐information: Access August 13th 2019.

3. ATIH (Agency for Information on Hospital Care)(2017):Report of the ambulatory surgery’s activity in ophthalmology.https://www.scansante.fr/applications/action‐gdr‐chirurgie‐ambulatoire‐spec: Accessed August 13th 2019.

4. Risk of Substantial Intraocular Bleeding With Novel Oral Anticoagulants

5. Peribulbar block in patients scheduled for eye procedures and treated with clopidogrel

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3